MetS was higher in PsA (36.5%) compared with PsC (27.1%) p=0.056). Adiponectin was significantly associated with PsA (p=0.005), the use of anti-tumour necrosis factor α therapy (p=0.03) and active joint count (p=0.001). This evidence concerns the gene ADIPOQ and metabolic syndrome.